Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab

被引：19
|
作者：
Sharaf, Basma M. [1 ]
Giddey, Alexander D. [2 ]
Alniss, Hasan [1 ,3 ]
Al-Hroub, Hamza M. [3 ]
El-Awady, Raafat [1 ,3 ]
Mousa, Muath [4 ]
Almehdi, Ahmed [4 ,5 ]
Soares, Nelson C. [1 ,3 ]
Semreen, Mohammad H. [1 ,3 ]
机构：
[1] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates
[2] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Cape Town, South Africa
[3] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates
[4] Univ Sharjah, Res Inst Sci & Engn, Sharjah, U Arab Emirates
[5] Univ Sharjah, Coll Sci, Dept Chem, Sharjah, U Arab Emirates
来源：
CANCER GENOMICS & PROTEOMICS | 2022年 / 19卷 / 01期
关键词：
Untargeted metabolomics; MCF-7; SkBr3; breast cancer cells; UHPLC-trapped ion TIMS-QTOF; tamoxifen; trastuzumab; TCA CYCLE; SUBTYPES; METASTASIS; METABOLISM; TAMOXIFEN; GROWTH; INHIBITION; GLYCOLYSIS; MECHANISM; HALLMARKS;
D O I：
10.21873/cgp.20305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background/Aim: Trastuzumab and tamoxifen are two of the most widely prescribed anti-cancer drugs for breast cancer (BC). To date, few studies have explored the impact of anticancer drugs on metabolic pathways in BC. Metabolomics is an emerging technology that can identify new biomarkers for tracking therapy response and novel therapeutic targets. Materials and Methods: We employed ultra-high-performance liquid chromatography-quadrupole time of flight mass spectrometry (UHPLC-QTOF-MS) to investigate changes in MCF-7 and SkBr3 cell lines treated with either tamoxifen, trastuzumab or a combination of both. The Bruker Human Metabolome Database (HMDB) metabolite library was used to match spectra and the MetaboScape software to assign each feature with a putative metabolite name or molecular formula for metabolite annotation. Results: A total of 98 metabolites were found to significantly differ in abundance in MCF-7 and SkBr3 treated cells. Moreover, the metabolic profile of the combination medication is similar to that of tamoxifen alone, according to functional enrichment analysis. Conclusion: Tamoxifen/trastuzumab treatment had a significant effect on pathways essential for the control of energy-production, which have previously been linked to cancer progression, and aggressiveness
引用
收藏
页码：79 / 93
页数：15
相关论文
共 50 条
  • [21] Increased constitutive activity of PKB/Akt in tamoxifen resistant breast cancer MCF-7 cells
    Jordan, NJ
    Gee, JMW
    Barrow, D
    Wakeling, AE
    Nicholson, RI
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 87 (02) : 167 - 180
  • [22] Role of mitochondria in tamoxifen-induced rapid death of MCF-7 breast cancer cells
    Kallio, A
    Zheng, A
    Dahllund, J
    Heiskanen, KM
    Härkönen, P
    APOPTOSIS, 2005, 10 (06) : 1395 - 1410
  • [23] Reduced glycosylation of SkBr3 breast cancer cells affects response to treatment
    Spector, A. F.
    Ramesh, B.
    Loizidou, M.
    Dwek, M.
    Welch, H.
    BRITISH JOURNAL OF SURGERY, 2014, 101 : 35 - 36
  • [24] Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells
    El Etreby, MF
    Liang, YY
    Wrenn, RW
    Schoenlein, PV
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 51 (02) : 149 - 168
  • [25] Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells
    Ignatov, Atanas
    Ignatov, Tanja
    Roessner, Albert
    Costa, Serban Dan
    Kalinski, Thomas
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) : 87 - 96
  • [26] Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells
    Pietkiewicz, P. P.
    Lutkowska, A.
    Lianeri, M.
    Jagodzinski, P. P.
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (01) : 54 - 57
  • [27] Chemoprevention with tamoxifen and Avemar® by inducing apoptosis on MCF-7 (ER+) breast cancer cells
    Tompa, A
    Kocsis, Z
    Maresek, Z
    Jakab, M
    Szende, B
    Hidvégi, M
    PROCEEDINGS OF THE 2ND CONGRESS OF THE WORLD SOCIETY FOR BREAST HEALTH, 2003, : 61 - 66
  • [28] Increased Constitutive Activity of PKB/Akt in Tamoxifen Resistant Breast Cancer MCF-7 Cells
    Nicola J. Jordan
    Julia M.W. Gee
    Denise Barrow
    Alan E. Wakeling
    Robert I. Nicholson
    Breast Cancer Research and Treatment, 2004, 87 : 167 - 180
  • [29] Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells
    Kim, IY
    Han, SY
    Moon, A
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2004, 67 (23-24): : 2025 - 2035
  • [30] The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells
    Coiret, Guyllaume
    Borowiec, Anne-Sophie
    Mariot, Pascal
    Ouadid-Ahidouch, Halima
    Matifat, Fabrice
    MOLECULAR PHARMACOLOGY, 2007, 71 (03) : 843 - 851
12345